HCA Healthcare, Inc. Common Stock (HCA)
Healthcare › Services-General Medical & Surgical Hospitals, NEC
Price History
Feb 9, 2026 — May 23, 2026Investment Snapshot
- P/E of 13.4 — reasonable valuation
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -745.6%
- Revenue growing at 7% annually
HCA Healthcare, Inc. Common Stock (HCA) is a Healthcare company operating in Services-General Medical & Surgical Hospitals, NEC, listed on the NYSE , with a market capitalisation of $87.4 billion . Key value metrics: P/E ratio 13.4, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
HCA Healthcare, Inc. Common Stock — Fundamental Analysis Summary
HCA Healthcare, Inc. Common Stock (HCA) trades at a trailing P/E of 13.4x — 47% below the Healthcare sector average of 25.2x.
On financial health, HCA shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -745.6% (sector average: -20.6%).
StockPik's composite Value Score for HCA is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HCA shows revenue growing at 7% year-over-year, with earnings growing at 18%.
HCA pays a modest dividend yield of 0.7%.